CClinicalTrials.gg
CompletedNCT05800262Updated Apr 5, 2023

Dynamic Stability Exercises in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder

An interventional study of Dynamic stability exercises in Hypermobility Syndrome and Hypermobile Ehlers-Danlos Syndrome, sponsored by University Hospital, Linkoeping. Completed at 2 sites in Sweden. Open to participants aged 18 Years to 67 Years. Per ClinicalTrials.gov, last updated 2023-04-05.

Sponsored by University Hospital, Linkoeping · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 11 months after the study started (first participant enrolled Apr 2019, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 67 Years
Sex
All
01

Study summary

Background:

Symptomatic hypermobility may lead to a number of restrictions in daily life. So far, there is a lack of effective treatments. A whole-body dynamic stability exercise intervention targets to stimulate the dynamic stability and activation of the proprioceptive system and thereby intends to improve patients' health. The aim of the current study was to examine the feasibility, acceptability and impact of a whole-body dynamic stability exercise intervention in patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.

The aim of the current study was to examine the feasibility, acceptability and impact of a dynamic stability exercise intervention in patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.

Methods:

This is a mixed-methods feasibility study. Fifteen patients (14 women and 1 man) with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder and chronic pain were recruited from two pain specialist clinics in the South-East of Sweden. A dynamic stability exercise program for daily home-exercise was applied during five physiotherapist led sessions distributed over seven weeks. Patient reported outcome measures (PROMs) included pain and function, psychological well-being and quality of life. The clinical tests included walking and balance. Through qualitative interviews patients and physiotherapists described their experiences of the assessments and intervention. Assessments were done at baseline, after the intervention, and at the 3-month follow-up.

Read the detailed description

The specific research questions are:

  1. Do retention rates, adherence rates and adverse events allow continuation to a large scale RCT?
  2. What are the tendencies of impact of the exercise program on pain, function, psychological well-being and quality of life?
  3. Which of the outcome measures used are appropriate and acceptable?
  4. What are the patients' and physiotherapists' experiences of the exercise program and protocol.
02

Conditions studied

  • Hypermobility Syndrome
  • Hypermobile Ehlers-Danlos Syndrome

Keywords

  • Hypermobility, exercise intervention, feasibility study, EDS
03

In context

Ehlers-Danlos Syndrome

75 studies on the registry are indexed under Ehlers-Danlos Syndrome; 25 are open to participants now.

This study's enrollment of 15 is below the median of 52 across 42 interventional studies indexed under Ehlers-Danlos Syndrome.

Browse Ehlers-Danlos Syndrome studies →

Lead sponsor

University Hospital, Linkoeping is the lead sponsor of 118 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Inclusion criteria were adults aged 18 to 67 years old, with generalized hypermobility (castori. A framework), persistent pain (i.e. longer than three months) in at least two of four quadrants of the body and ability to perform the exercises.

Exclusion criteria

Exclusion Criteria:

Exclusion criteria were cancer-related pain, underlying neurological disease, presence of severe psychiatric disorders, known substance abuse, patients in the process of finding optimal medication as well as patients with previous experience of similar exercises.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Dynamic stability exercise

    A dynamic stability exercise program for daily home-exercise was applied during five physiotherapist led sessions distributed over seven weeks.

    Behavioral: Dynamic stability exercises

Interventions

  • BehavioralDynamic stability exercises

    A dynamic stability exercise program for daily home-exercise was applied during five physiotherapist led sessions distributed over seven weeks.

06

What researchers measure

Primary outcomes

  1. Identification of suitable measures for a forthcoming RCT

    Qualitative and quantitative evaluation through secondaty outcome measures and qualitative interviews with patients and physiotherapists

    Time frame: Nine months

Secondary outcomes

  1. Pain numeric rating scale

    Rating of mean pain last week

    Time frame: 6 months

  2. Functional Rating Index

    Disability regarding daily activities

    Time frame: 6 months

  3. Multidimensional Fatigue Inventory 20

    Five subscales measuring general fatigue, physical fatigue, reduced motivation, reduced activity and mental fatigue. Item 19 was removed according to Hagelin (2009).

    Time frame: 6 months

  4. Arthritis Self-efficacy scale

    Twenty items divided into three sub-scales for self-efficacy for physical function, other symptoms and pain.

    Time frame: 6 months

  5. Stress and Crisis Inventory-93

    Thirty-five items on physical and psychological symptoms that can be clinical manifestations of stress.

    Time frame: 6 months

  6. Tampa Scale for Kinesiophobia

    Questionnaire measuring kinesiophobia, 17 items.

    Time frame: 6 months

  7. Orthostatic Hypotension Questionnaire

    Assessment of symptoms and daily activity in relation to orthostatic hypotension. 10 items.

    Time frame: 6 months

  8. European Quality of Life questionnaire (EQ-5D-3L)

    Health related quality of life

    Time frame: 6 months

  9. Berg balance scale

    14 tasks common in daily activities testing balance

    Time frame: 6 months

  10. Bruininks-Oseretsky Test of Motor Proficiency 2

    Nine tasks testing balance

    Time frame: 6 months

  11. Timed up and go

    Mobility, balance, walking ability and fall risk in older adults

    Time frame: 6 months

  12. 2-minute walk test

    Walking ability

    Time frame: 6 months

  13. Wii balance test using a Wii Balance Board

    Balance test. Centre of pressure path length, anterio-posterior and medio-lateral sway measured standing on two feet with eyes open and eyes closed, standing on dominant foot and on non-dominant foot with eyes open. Tests performed according to Schmidt (2017), but during 60 seconds instead of 30 seconds.

    Time frame: 6 months

07

Study locations

2 sites
  • Samrehab Smärtenheten, the Hospital of Västervik
    Västervik, Kalmar Län 59333, Sweden
  • Pain and rehabilitation center, University Hospital of Linkoping.
    Linköping, Östergötland 587 37, Sweden
08

References and documents

Individual participant data

Plan to share: Yes — Data is available from the authors on reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05800262
Lead sponsor
University Hospital, Linkoeping
Collaborators
Linkoeping University, Länssjukhuset i Kalmar län, Medical Research Council of Southeast Sweden
Responsible party
Helena Romero (Physiotherapist, University Hospital, Linkoeping) — Principal investigator
First posted
Apr 5, 2023
Start date
Apr 19, 2019
Primary completion
Sep 12, 2019
Completion
Dec 12, 2019
Last update
Apr 5, 2023

Study contacts

Helena Romero
principal investigator · Smärt- och rehabcentrum, Universitetssjukhuset i Linköping

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion